TRADING UPDATES: Aptamer gets more Unilever work; Creo "confident"
21st Jul 2025 19:59
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
| Price | 13.00p on 04-09-2025 at 13:26:31 |
|---|---|
| Change | -0.125p -0.95% |
| Buy | 13.25p |
| Sell | 12.75p |
| Last Trade: | Buy 100.00 at 13.1216p |
| Day's Volume: | 340,706 |
| Last Close: | 13.125p |
| Open: | 13.15p |
| ISIN: | GB00BZ1BLL44 |
| Day's Range | 13.00p - 13.15p |
| 52wk Range: | 9.30p - 32.50p |
| Market Capitalisation: | £53.62m |
| VWAP: | 12.82244p |
| Shares in Issue: | 412.47m |
Sector: Medical Services
Listed In: FTSE AIM All-Share,
Creo Medical (CREO) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 100 | 13.1216p | Ordinary |
14:26:30 - 04-Sep-25 |
| Sell* | 10,200 | 12.80p | Ordinary |
13:48:28 - 04-Sep-25 |
| Unknown* | 250,000 | 12.75p | Ordinary |
13:14:59 - 04-Sep-25 |
| Buy* | 7,582 | 13.1216p | Ordinary |
13:10:08 - 04-Sep-25 |
| Sell* | 788 | 12.80p | Ordinary |
11:27:17 - 04-Sep-25 |
| Buy* | 15 | 13.2372p | Ordinary |
10:49:00 - 04-Sep-25 |
| Buy* | 762 | 13.1216p | Ordinary |
10:44:28 - 04-Sep-25 |
| Buy* | 1,604 | 13.1216p | Ordinary |
09:34:30 - 04-Sep-25 |
| Buy* | 45 | 13.2372p | Ordinary |
09:30:31 - 04-Sep-25 |
| Sell* | 1,482 | 13.01p | Ordinary |
09:26:11 - 04-Sep-25 |
Creo Medical (CREO) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 12th Aug 2025 4:56 pm | RNS | Director/PDMR Share Dealing |
| 4th Aug 2025 7:00 am | RNS-R | Speedboat® patient testimonial |
| 24th Jul 2025 7:00 am | RNS | Award of Shares under SIP and Director Dealings |
| 21st Jul 2025 7:00 am | RNS | H1’25 Trading Update |
| 10th Jul 2025 7:00 am | RNS-R | MicroBlate™ Flex begins lung tumour clinical study |
| 9th Jul 2025 9:41 am | RNS | PDMR Options Revision |
| 30th Jun 2025 7:00 am | RNS | Change of Nominated Adviser |
| 26th Jun 2025 11:08 am | RNS | Result of AGM |
| 26th Jun 2025 7:00 am | RNS | AGM Statement and Directorate Changes |
| 11th Jun 2025 7:00 am | RNS-R | U.S. FDA clearance for SpydrBlade™ Flex |